Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Weight Loss Through the Use… >
Weight Loss Through the Use of Intestinal Barrier Sleeves

Published: October 10, 2013.
By Helmholtz Zentrum München - German Research Center for Environmental Health
http://www.gsf.de

Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures. An international team of scientists led by Dr. Kirk Habegger, Metabolic Disease Institute, University of Cincinnati, and Prof. Dr. Matthias Tschöp, Scientific Director of the Helmholtz Diabetes Center (HDC) at the Helmholtz Zentrum München (HMGU), Partner of the German Center for Diabetes Research (DZD), have now developed an equally efficient but less invasive surgical method, thus paving the way for the development of novel safe and efficient anti-obesity therapies.

In their study, a flexible tube, called a DES (duodenal-endoluminal sleeve), was placed in the small intestine. Tschöp, Habegger, and colleagues observed that this intervention in an animal model potently corrects obesity while improving glucose metabolism. The metabolic benefits of this novel surgical intervention seem to be mediated via reduced nutrient absorption in the intestinal lumen and reactive mucous membrane growth in the other intestinal sections, a shift which may lead to improved nutrient utilization. The intervention carries the great advantage that it is less invasive and removable at any time.

The method is consequently seen as a promising approach to treat obesity and diabetes. Further studies now aim to clarify which influence this novel surgical technique has on the complex neuroendocrine network that controls energy metabolism. The long-term goal based on such better understanding is to optimize devices to the level where they can be used successfully in humans, potentially in combination with hormone based drug therapies. (Also see press release "Enhancing weight loss: Gastric banding with hormone therapy.")

The numerous conditions associated with overweight and obesity, such as type 2 diabetes, are among the major widespread diseases in Germany. They are the focus of the research at the Helmholtz Zentrum München.


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Individual 
2/28/14 
Diabetes And Obesity More Common in Socioeconomically Deprived Regions
By Helmholtz Zentrum München - German Research Center for Environmental Health
Living in a socioeconomically deprived region is a risk factor for being affected by diabetes mellitus and obesity. This holds true regardless of the individual social status of the …
Diabetes 
4/20/11 
Einstein Researchers Find Link Between Brain Molecule And Obesity And Diabetes
By Albert Einstein College of Medicine
April 19, 2011 – (BRONX, NY) – The brain's hypothalamus plays a key role in obesity and one of its major complications – type 2 diabetes. Nerve cells in …
Muscle 
3/1/11 
★ 

Scientists Discover Genetic Switch That Increases Muscle Blood Supply
By University of Texas Health Science Center at Houston
Appetite 
8/25/11 
Slim Down by Targeting the Hormone Uroguanylin
By Journal of Clinical Investigation
The number of people who are obese and suffer one or more of its associated health problems (including type 2 diabetes) is escalating dramatically. Researchers are seeking to identify …
Basaran 
6/23/14 
Gut Microbe Levels Are Linked to Type 2 Diabetes And Obesity
By The Endocrine Society
CHICAGO, IL — People with Type 2 diabetes or obesity have changes in the composition of their intestinal micro-organisms—called the gut microbiota—that healthy people do not have, researchers from …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition